NDC 68071-5250-06 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-5250
- Requested NDC
- 68071-5250-06
- Package NDCs from labels
- 68071-5250-2, 68071-5250-6, 68071-5250-3, 68071-5250-06
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2024-07-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam Tablets USP CIV | NuCare Pharmaceuticals,Inc. | 2024-07-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-5250-2 | Lorazepam | 20 in 1 BOTTLE | TABLET | 20 | 7 | |
| 68071-5250-3 | Lorazepam | 3 in 1 BOTTLE | TABLET | 3 | 7 | |
| 68071-5250-6 | Lorazepam | 6 in 1 BOTTLE | TABLET | 6 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-5250 | LORAZEPAM TABLET [NUCARE PHARMACEUTICALS,INC.] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240719_a4fe8df0-3ce8-b8b8-e053-2995a90a28f4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Preferred Pharmaceuticals Inc. | 4a50329b-b272-4164-bddf-0d6cea3d7a23 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | ANDA203572 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | Redpharm Drug | 52614947-c96c-3361-e063-6394a90ae172 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | American Health Packaging | 6dfbe8be-168c-44e9-acfa-fa838b92d3b7 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | 11372b3d-52c0-4694-8c88-4b72d3fda9d0 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | ANDA203572 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | Coupler LLC | 51119efa-c1a3-71f0-e063-6394a90a9e2a | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | Coupler LLC | 5114810c-025f-6113-e063-6294a90af538 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | Fresenius Kabi USA, LLC | 462a13da-259a-40e7-bd5b-f7f42ae025b7 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| LORAZEPAM | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 0418ad09-3069-4381-9a8f-e41b234fdac6 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | ANDA203572 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | A-S Medication Solutions | 8361519b-be1a-4542-a782-d7cdfa153e86 | 2026-01-24 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | a0a33933-f697-4d3b-ba99-8a995a4b6c6b | 2026-01-09 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| LORAZEPAM | LORAZEPAM | DIRECT RX | 4832f02d-289c-2fe6-e054-00144ff8d46c | 2026-01-08 | Warnings, Adverse reactions | 197900 O26FZP769L |
| LORAZEPAM | LORAZEPAM | Aurolife Pharma LLC | 5b851f67-309d-4ef3-8b4b-ade8908256ea | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | ANDA203572 13107-084 197901 197900 197902 67012944-0947-4e64-adab-869993f2f709 5b851f67-309d-4ef3-8b4b-ade8908256ea O26FZP769L |
| Lorazepam | LORAZEPAM | RedPharm Drug, Inc. | 891b2c10-942f-0e4d-e053-2995a90af028 | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | PharmPak, Inc. | b6e4d2c7-10c0-4d77-be7b-caa3d3b86997 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 1f79a5a1-0c40-45cf-8994-51f5ba3a5938 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 0681c8db-ff09-4258-a5e0-76a26b0ea0af | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7afd9a59-3463-4eda-8cf3-ef90be05de3d | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7999b9c3-6185-4e4e-a4c3-d5d33d6c31d6 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | American Health Packaging | 45e31a87-a8db-4dda-b94b-83535b62e8e2 | 2025-09-14 | Boxed warning, Warnings, Adverse reactions | ANDA203572 197901 197900 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 08a30230-fc95-9025-e063-6394a90ae21b | 2025-08-05 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.